Neumora Therapeutics nets over $500m

Neumora Therapeutics Inc, a clinical-stage biotechnology company, has raised over $500 million in funding.

Neumora Therapeutics Inc, a clinical-stage biotechnology company, has raised over $500 million in funding. The backers included ARCH Venture Partners.

Source: Press Release